MedinCell S.A. (EPA:MEDCL)
25.78
-1.04 (-3.88%)
Jun 3, 2026, 5:35 PM CET
MedinCell Employees
MedinCell had 145 employees as of September 30, 2025. The number of employees increased by 14 or 10.69% since the number was reported on March 31, 2025.
Employees
145
Change
14
Growth
10.69%
Revenue / Employee
€223,717
Profits / Employee
€137,572
Market Cap
962.95M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 145 | 14 | 10.69% |
| Mar 31, 2025 | 131 | -3 | -2.24% |
| Mar 31, 2024 | 134 | 3 | 2.29% |
| Mar 31, 2023 | 131 | -8 | -5.76% |
| Mar 31, 2022 | 139 | 1 | 0.72% |
| Mar 31, 2021 | 138 | 5 | 3.76% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cellectis | 229 |
| Genfit | 188 |
| Innate Pharma | 164 |
| DBV Technologies | 161 |
| Transgene | 145 |
| Nanobiotix | 100 |
| Inventiva | 77 |
MedinCell News
- 6 days ago - Medincell: Videoconference and Publication of Annual Financial Results, Tuesday, June 16, 2026 - Business Wire
- 8 days ago - Medincell to Participate in Jefferies and Evercore Investor Conferences in the U.S. in June - Business Wire
- 12 days ago - Teva: European Medicines Agency Accepts Marketing Authorization Application For TEV-'749 - Nasdaq
- 22 days ago - MedinCell Transcript: R&D Day 2026 - Transcripts
- 6 weeks ago - Medincell to Host an Online R&D Day on Tuesday, May 12, 2026 - Business Wire
- 3 months ago - Medincell to Present at the TD Cowen 46th Annual Healthcare Conference in Boston, March 2-4, 2026 - Business Wire
- 3 months ago - FDA Accepts NDA For Teva And Medincell's Olanzapine LAI In Schizophrenia Treatment - Nasdaq
- 4 months ago - Medincell - UZEDY®: Net Sales Increased from $117M in 2024 to $191M in 2025 (+63%) - Business Wire